The human digestive system is a balanced ecosystem of good and bad bacteria. Disruption of this balance can lead to digestive discomfort. Nearly half of the world’s population regularly experiences functional gastrointestinal disorders, and 5-35% suffer from irritable bowel syndrome (IBS) with symptoms like bloating, constipation, and abdominal pain.
Probi Digestis® contains Lactoplantibacillus plantarum 299v (LP299V®), a well-researched probiotic clinically proven to support gastrointestinal health and restore balance.
Antibiotics and Probiotics for Irritable Bowel Syndrome
Authors: Goodoory, V.C., Ford, A.C.
Publication: Drugs 83(8):687-699.
https://pubmed.ncbi.nlm.nih.gov/37184752/
Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics
Authors: Lönnermark, E., Friman, V., Lappas, G., Sandberg, T., Berggren, A., Alderberth, I.
Publication: Journal of Clinical Gastroenterology 44: 106-112
https://pubmed.ncbi.nlm.nih.gov/19727002/
Lactobacillus plantarum 299v Reduces the Incidence of Clostridium Difficile Infection in Nephrology and Transplantation Ward-Results of One Year Extended Study
Authors: Dudzicz, S., Kujawa-Szewieczek, A., Kwiecień, K., Więcek, A., Adamczak, M.
Publication: Nutrients, 10(11), 1574.
https://pubmed.ncbi.nlm.nih.gov/30355985/
Lactobacillus plantarum 299v Reduces the Incidence of Clostridium difficile Infection in Nephrology and Transplantation Ward-Results of One Year Extended Study
Authors: Dudzicz, S., Kujawa-Szewieczek, A., Kwiecień, K., Więcek, A., Adamczak, M.
Publication: Nutrients, 10(11), 1574.
https://pubmed.ncbi.nlm.nih.gov/30355985/
Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment – real-life data of a non-interventional study in Germany
Authors: Krammer H, Storr M, Madisch A, Riffel J
Publication: Z Gastroenterol 2021; 59(02): 125-134
Please note that the publication is only available in German but with an abstract in English
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1340-0204
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome
Authors: Niedzielin K, Kordecki H, Birkenfeld B
Publication: Eur J Gastroenterol Hepatol. 2001;13(10):1143-7.
https://europepmc.org/article/med/11711768
Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome
Authors: Nobaek S, Johansson M L, Molin G, Ahrné S, Jeppsson B
Publication: Am J Gastroenterol. 2000;95(5):1231-8.
https://journals.lww.com/ajg/Abstract/2000/05000/Alteration_of_Intestinal_Microflora_Is_Associated.23.aspx
Antibiotics and Probiotics for Irritable Bowel Syndrome
Authors: Goodoory, V.C., Ford, A.C.
Publication: Drugs 83(8):687-699.
https://pubmed.ncbi.nlm.nih.gov/37184752/
Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics
Authors: Lönnermark, E., Friman, V., Lappas, G., Sandberg, T., Berggren, A., Alderberth, I.
Publication: Journal of Clinical Gastroenterology 44: 106-112
https://pubmed.ncbi.nlm.nih.gov/19727002/
Lactobacillus plantarum 299v Reduces the Incidence of Clostridium Difficile Infection in Nephrology and Transplantation Ward-Results of One Year Extended Study
Authors: Dudzicz, S., Kujawa-Szewieczek, A., Kwiecień, K., Więcek, A., Adamczak, M.
Publication: Nutrients, 10(11), 1574.
https://pubmed.ncbi.nlm.nih.gov/30355985/
Lactobacillus plantarum 299v Reduces the Incidence of Clostridium difficile Infection in Nephrology and Transplantation Ward-Results of One Year Extended Study
Authors: Dudzicz, S., Kujawa-Szewieczek, A., Kwiecień, K., Więcek, A., Adamczak, M.
Publication: Nutrients, 10(11), 1574.
https://pubmed.ncbi.nlm.nih.gov/30355985/
Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment – real-life data of a non-interventional study in Germany
Authors: Krammer H, Storr M, Madisch A, Riffel J
Publication: Z Gastroenterol 2021; 59(02): 125-134
Please note that the publication is only available in German but with an abstract in English
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1340-0204
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome
Authors: Niedzielin K, Kordecki H, Birkenfeld B
Publication: Eur J Gastroenterol Hepatol. 2001;13(10):1143-7.
https://europepmc.org/article/med/11711768
Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome
Authors: Nobaek S, Johansson M L, Molin G, Ahrné S, Jeppsson B
Publication: Am J Gastroenterol. 2000;95(5):1231-8.
https://journals.lww.com/ajg/Abstract/2000/05000/Alteration_of_Intestinal_Microflora_Is_Associated.23.aspx
Contact us:
Sitemap: